Asimov Press

Long before Ozempic and Mounjaro, there were mitochondrial uncouplers. While deadly if not used with care, it might be time for them to make a comeback. By Alex Telford.Read every article from Asimov Press at press.asimov.com.

The history of humanity’s pharmacopeia is often muddied by folklore. What can the origins of aspirin teach us about separating fact from fiction? By Sean Harrison.Read every article from Asimov Press, for free, by visiting press.asimov.com.

A science fiction story brought to life through a pro-GMO dinner. By Xander Balwit.Read every article by Asimov Press, and join future events, by visiting press.asimov.com.

Prominent scientists continue to claim life is “just” slime on a spinning rock. However, in an age when the rarity and fragility of life are increasingly evident, it’s time to retire the metaphor.By Thomas Moynihan.Read every article, for free, at press.asimov.com.

The slow growth of model organisms delays biological research. Engineering cells to divide more quickly could speed it up. By Kamal Nahas.Read every article, for free, at press.asimov.com.

Researchers at the Institute for Protein Design have made a computationally-designed, multi-step enzyme.

(Sci-Fi) Bioart emerges where biological science, technology, and aesthetics collide. For one terminally ill artist, it offered a chance at immortality. By Spencer Nitkey.Read all our articles for free at press.asimov.com.

Toxic amino acids, peptides, and proteins — which first evolved as molecular weapons deployed by species in conflict — can also serve as blueprints for pharmaceutical innovation. By Noah Whiteman.Read all of our articles for free at press.asimov.com.

Further evidence of biological intelligence. Read every article, for free, at press.asimov.com.

From the archives: What it will take to transform bacteriophages into a 21st-century medicine. By Tom Ireland.